{"id":"W4379878475","doi":"10.1038/s41591-023-02381-w","title":"Signaling-specific inhibition of the CB1 receptor for cannabis use disorder: phase 1 and phase 2a randomized trials","year":2023,"lang":"en","type":"article","venue":"Nature Medicine","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"ca_institutions":"Université de Moncton","funders":"Plan Nacional sobre Drogas; Mission Interministérielle de Lutte Contre les Drogues et les Conduites Addictives; Université de Bordeaux; LabEx BRAIN; Centre National de la Recherche Scientifique; Institut National de la Santé et de la Recherche Médicale; Ministerio de Sanidad, Servicios Sociales e Igualdad; National Institute on Drug Abuse; Agence Nationale de la Recherche; Bpifrance","keywords":"Placebo; Cannabinoid; Cannabis; Medicine; Pharmacology; Randomization; Cannabinoid receptor; Randomized controlled trial; Adverse effect; Delta-9-tetrahydrocannabinol; Crossover study; Internal medicine; Anesthesia; Receptor; Psychiatry; Agonist; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002765224,0.002021618,0.002549839,0.000608391,0.0006058756,0.001258083,0.00104604,0.002394817,0.008035103],"category_scores_gemma":[0.002308731,0.0007589994,0.002491469,0.0006678568,0.00106812,0.0009947356,0.0003687094,0.002802106,0.001080546],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000940433,"about_ca_system_score_gemma":0.001510846,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001247471,"about_ca_topic_score_gemma":0.003133021,"domain_scores_codex":[0.9990938,0.0004315889,0.00006779438,0.0001702367,0.00009369044,0.0001429685],"domain_scores_gemma":[0.9988821,0.0002769076,0.0002984139,0.00009883468,0.000170378,0.0002732822],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9287252,0.0147494,0.0006108065,0.00307964,0.002272835,0.00006338466,0.00007881881,0.0004210224,0.007860923,0.0004282014,0.003425727,0.03828408],"study_design_scores_gemma":[0.9249165,0.06938256,0.001355194,0.0001653618,0.0007792094,0.00004564781,0.00002365886,0.0002825233,0.0006907618,0.0003108462,0.002026213,0.00002151343],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9011154,0.04149942,0.004917722,0.002960287,0.001947676,0.03325687,0.007035986,0.0005231182,0.006743559],"genre_scores_gemma":[0.9195463,0.02493409,0.007942034,0.003878847,0.001150636,0.03112553,0.003852769,0.00008530526,0.007484446],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008035103,"threshold_uncertainty_score":0.02688009,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05082259799235135,"score_gpt":0.3930231512805788,"score_spread":0.3422005532882275,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}